Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) is facing a turbulent start to the week, with its pre-market price dropping an additional 7% after Friday’s 5% decline.
Shares of Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) traded up 114.89% after the company announced that it has received the Emergency Use Authorization (EUA) from FDA
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.